Patient Pathfinder: Clinical Trials
Clinical Trials for Lung Cancer
Every life-saving or life-extending treatment that’s available today for cancer started its journey in a clinical trial. A clinical trial is a study that helps doctors better understand cancer, and discover safer and more effective ways to treat it.
Clinical trials also give patients a chance to try a treatment before it’s approved by the U.S. Food and Drug Administration.
There are 986 active Lung Cancer trials
A Trial of Pembrolizumab in Combination With Chemotherapy and Radiotherapy in Stage III NSCLC (KEYNOTE-799, MK-3475-799).
Study Type: Interventional Phase 2
NGS Screening Protocol to Detect Mutation of KEAP1 or NRF2/NFE2L2 Genes for the KEAPSAKE (CX-839-014) Trial
Study Type: Interventional Early Phase 1
A Feasibility Study to Further the Development of Lung Cancer-based Precision Medicine
Study Type: Interventional
HER3-DXd (Patritumab Deruxtecan; U3-1402) in Combination With Osimertinib in Subjects With Locally Advanced or Metastatic EGFR-mutated Non-Small Cell Lung Cancer
Study Type: Interventional Phase 1
Nivolumab for the Reversal of Squamous Dysplasia in High Risk Current and Former Smokers
Study Type: Interventional Phase 2
Exparel and Marcaine for Pain Management in Thoracoscopic Lobectomy Patients
Study Type: Interventional Phase 3
Supportive Care Mobile Application for Patients With NSCLC
Study Type: Interventional
Osimertinib With Stereotactic Radiosurgery (SRS) in Brain Metastases From EGFR Positive NSCLC
Study Type: Interventional Phase 1
There are 986 active Lung Cancer trials
Filter Results
Phase
Study Type
Need more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start NowNeed more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start Now